<!DOCTYPE html><html><head><link href='https://fonts.googleapis.com/css?family=Spectral' rel='stylesheet'><style>body {    font-family: 'Spectral';font-size: 14px;}</style></head><body><b>Search Term: </b>("sickle cell disease" OR "beta thalassemia") AND ("gene therapy" OR "genome editing" OR "mRNA therapy")<br><b>Date run: </b>2020/01/07<br><br><h2>PubMed Articles</h2> <br><b><a href="https://ncbi.nlm.nih.gov/pubmed/31742431">Perspectives of Sickle Cell Disease Stakeholders on Heritable Genome Editing.</a></b><br><b>Journal:</b> CRISPR J<br><b>Two-year IF:</b> 0.0<br><br><b><a href="https://ncbi.nlm.nih.gov/pubmed/31576160">Gene Therapy For Beta-Thalassemia: Updated Perspectives.</a></b><br><b>Journal:</b> Appl Clin Genet<br><b>Two-year IF:</b> 3.67<br><br><b><a href="https://ncbi.nlm.nih.gov/pubmed/31766235">The Scope for Thalassemia Gene Therapy by Disruption of Aberrant Regulatory Elements.</a></b><br><b>Journal:</b> J Clin Med<br><b>Two-year IF:</b> 6.78<br><br><b><a href="https://alexmakijokela.github.io/202001071421_sickle.html#pubmed">More Results...</a></b><br><br><h2>Companies</h2> <br><b><a href="https://www.linkedin.com/company/crispr-therapeutics/about/">CRISPR Therapeutics</a></b><br><br><b><a href="https://www.linkedin.com/company/orchard-therapeutics/about/">Orchard Therapeutics</a></b><br><br><b><a href="https://www.linkedin.com/company/trucode-gene-repair-inc/about/">Trucode Gene Repair, Inc.</a></b><br><br><b><a href="https://alexmakijokela.github.io/202001071421_sickle.html#companies">More Results...</a></b><br><br><h2>Patents</h2> <br><b><a href="http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=47&p=1&f=G&l=50&d=PTXT&S1=((%22sickle+cell+disease%22+OR+%22beta+thalassemia%22)+AND+((%22gene+therapy%22+OR+%22genome+editing%22)+OR+%22mRNA+therapy%22))&OS=+("sickle+cell+disease"+OR+"beta+thalassemia")+AND+("gene+therapy"+OR+"genome+editing"+OR+"mRNA+therapy")&RS=(("sickle+cell+disease"+OR+"beta+thalassemia")+AND+(("gene+therapy"+OR+"genome+editing")+OR+"mRNA+therapy"))">Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription</a></b><br><b>Patent date:</b> October 15, 2019<br><br><b><a href="http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=26&p=1&f=G&l=50&d=PTXT&S1=((%22sickle+cell+disease%22+OR+%22beta+thalassemia%22)+AND+((%22gene+therapy%22+OR+%22genome+editing%22)+OR+%22mRNA+therapy%22))&OS=+("sickle+cell+disease"+OR+"beta+thalassemia")+AND+("gene+therapy"+OR+"genome+editing"+OR+"mRNA+therapy")&RS=(("sickle+cell+disease"+OR+"beta+thalassemia")+AND+(("gene+therapy"+OR+"genome+editing")+OR+"mRNA+therapy"))">Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription</a></b><br><b>Patent date:</b> November 26, 2019<br><br><b><a href="http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=1&p=1&f=G&l=50&d=PTXT&S1=((%22sickle+cell+disease%22+OR+%22beta+thalassemia%22)+AND+((%22gene+therapy%22+OR+%22genome+editing%22)+OR+%22mRNA+therapy%22))&OS=+("sickle+cell+disease"+OR+"beta+thalassemia")+AND+("gene+therapy"+OR+"genome+editing"+OR+"mRNA+therapy")&RS=(("sickle+cell+disease"+OR+"beta+thalassemia")+AND+(("gene+therapy"+OR+"genome+editing")+OR+"mRNA+therapy"))">Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription</a></b><br><b>Patent date:</b> January 7, 2020<br><br><b><a href="https://alexmakijokela.github.io/202001071421_sickle.html#patents">More Results...</a></b><br><br><br><b><a href="https://alexmakijokela.github.io/202001071421_sickle.html">Link to Full Search Results</a></b><br></body></html>